Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales ...

SAN FRANCISCO, CA / ACCESS Newswire / March 4, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC) ("Tivic" or the "Company"), a late-stage immunotherapeutics company, today announced that its Board of ...

"Another politician might find questions, such as the Pizzagate questions, amusing or they might welcome the distraction. She doesn't," one expert said. "She is exasperated and she shows it." ...

EET Espoo, Finland, March 5, 2026: Herantis Pharma Plc ("Herantis") a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, releases today the ...

These 2-pot calipers can be strong enough for way more than you expect, especially for winter enduro riding.

The MarketWatch News Department was not involved in the creation of this content.-- Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which ...

“Picking out the best guitar moment on The Dark Side Of The Moon is a tough one,” Bellamy admitted. “But I have to say Money ...

Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID March 4, 2026 4:15 ...

LivaNova has outperformed the market, but future upside is uncertain due to slowing growth and higher valuation. See why LIVN stock is downgraded to hold.

Company announcement Herantis Pharma Plc | Company Release | March 5, 2026 at 08:00 EET Herantis Pharma releases 2H and FY 2025 report today Espoo, Finland, March 5, 2026: Herantis Pharma Plc ("Herant ...

Wentworth residents will notice a familiar face on season 6 of MasterChef South Africa. Candice Rall Meth is sowing judges ...

Threat actors are operationalizing AI to scale and sustain malicious activity, accelerating tradecraft and increasing risk for defenders, as illustrated by recent activity from North Korean groups ...